full wwpdb nmr structure validation report...
TRANSCRIPT
Full wwPDB NMR Structure Validation Report iO
May 28, 2020 � 07:10 pm BST
PDB ID : 1A5RTitle : STRUCTURE DETERMINATION OF THE SMALL UBIQUITIN-
RELATED MODIFIER SUMO-1, NMR, 10 STRUCTURESAuthors : Bayer, P.; Arndt, A.; Metzger, S.; Mahajan, R.; Melchior, F.; Jaenicke, R.;
Becker, J.Deposited on : 1998-02-18
This is a Full wwPDB NMR Structure Validation Report for a publicly released PDB entry.
We welcome your comments at [email protected] user guide is available at
https://www.wwpdb.org/validation/2017/NMRValidationReportHelpwith speci�c help available everywhere you see the iO symbol.
The following versions of software and data (see references iO) were used in the production of this report:
Cyrange : Kirchner and Güntert (2011)NmrClust : Kelley et al. (1996)
MolProbity : 4.02b-467Percentile statistics : 20191225.v01 (using entries in the PDB archive December 25th 2019)
RCI : v_1n_11_5_13_A (Berjanski et al., 2005)PANAV : Wang et al. (2010)
ShiftChecker : 2.11Ideal geometry (proteins) : Engh & Huber (2001)
Ideal geometry (DNA, RNA) : Parkinson et al. (1996)Validation Pipeline (wwPDB-VP) : 2.11
Page 2 Full wwPDB NMR Structure Validation Report 1A5R
1 Overall quality at a glance iO
The following experimental techniques were used to determine the structure:SOLUTION NMR
The overall completeness of chemical shifts assignment was not calculated.
Percentile scores (ranging between 0-100) for global validation metrics of the entry are shown inthe following graphic. The table shows the number of entries on which the scores are based.
MetricWhole archive(#Entries)
NMR archive(#Entries)
Clashscore 158937 12864Ramachandran outliers 154571 11451
Sidechain outliers 154315 11428
The table below summarises the geometric issues observed across the polymeric chains and their�t to the experimental data. The red, orange, yellow and green segments indicate the fractionof residues that contain outliers for >=3, 2, 1 and 0 types of geometric quality criteria. A cyansegment indicates the fraction of residues that are not part of the well-de�ned cores, and a grey seg-ment represents the fraction of residues that are not modelled. The numeric value for each fractionis indicated below the corresponding segment, with a dot representing fractions <=5%
Mol Chain Length Quality of chain
1 A 103
Page 3 Full wwPDB NMR Structure Validation Report 1A5R
2 Ensemble composition and analysis iO
This entry contains 10 models. Model 1 is the overall representative, medoid model (most similarto other models).
The following residues are included in the computation of the global validation metrics.
Well-de�ned (core) protein residuesWell-de�ned core Residue range (total) Backbone RMSD (Å) Medoid model
1 A:21-A:92 (72) 0.36 1
Ill-de�ned regions of proteins are excluded from the global statistics.
Ligands and non-protein polymers are included in the analysis.
The models can be grouped into 3 clusters and 2 single-model clusters were found.
Cluster number Models1 2, 7, 82 3, 6, 93 1, 4
Single-model clusters 5; 10
Page 4 Full wwPDB NMR Structure Validation Report 1A5R
3 Entry composition iO
There is only 1 type of molecule in this entry. The entry contains 1622 atoms, of which 803 arehydrogens and 0 are deuteriums.
� Molecule 1 is a protein called SUMO-1.
Mol Chain Residues Atoms Trace
1 A 103Total C H N O S1622 506 803 140 168 5
0
Page 5 Full wwPDB NMR Structure Validation Report 1A5R
4 Residue-property plots iO
4.1 Average score per residue in the NMR ensemble
These plots are provided for all protein, RNA and DNA chains in the entry. The �rst graphic is thesame as shown in the summary in section 1 of this report. The second graphic shows the sequencewhere residues are colour-coded according to the number of geometric quality criteria for whichthey contain at least one outlier: green = 0, yellow = 1, orange = 2 and red = 3 or more. Stretchesof 2 or more consecutive residues without any outliers are shown as green connectors. Residueswhich are classi�ed as ill-de�ned in the NMR ensemble, are shown in cyan with an underlinecolour-coded according to the previous scheme. Residues which were present in the experimentalsample, but not modelled in the �nal structure are shown in grey.
• Molecule 1: SUMO-1
Chain A:
G-1
S0
M1
S2
D3
Q4
E5
A6
K7
P8
S9
T10
E11
D12
L13
G14
D15
K16
K17
E18
G19
E20
Y21
I22
K23
L24
K25
V26
I27
D30
S31
S32
E33
I34
H35
F36
K37
V38
K39
M40
T41
T42
H43
L44
K45
K46
L47
K48
E49
S50
Y51
C52
Q53
R54
Q55
G56
V57
P58
M59
N60
S61
L62
R63
F64
L65
F66
E67
G68
Q69
R70
I71
A72
D73
N74
H75
T76
P77
K78
E79
L80
G81
M82
E83
E84
E85
D86
V87
I88
E89
V90
Y91
Q92
E93
Q94
T95
G96
G97
H98
S99
T100
V101
4.2 Scores per residue for each member of the ensemble
Colouring as in section 4.1 above.
4.2.1 Score per residue for model 1 (medoid)
• Molecule 1: SUMO-1
Chain A:
G-1
S0
M1
S2
D3
Q4
E5
A6
K7
P8
S9
T10
E11
D12
L13
G14
D15
K16
K17
E18
G19
E20
Y21
I22
K23
L24
K25
V26
I27
G28
Q29
D30
S31
S32
E33
I34
H35
F36
K37
V38
K39
M40
T41
T42
H43
L44
K45
K46
L47
K48
E49
S50
Y51
C52
Q53
R54
Q55
G56
V57
P58
M59
L62
R63
F64
L65
F66
E67
G68
Q69
R70
I71
A72
D73
N74
H75
T76
P77
K78
E79
L80
G81
M82
E83
E84
E85
D86
V87
I88
E89
V90
E93
Q94
T95
G96
G97
H98
S99
T100
V101
4.2.2 Score per residue for model 2
• Molecule 1: SUMO-1
Chain A:
Page 6 Full wwPDB NMR Structure Validation Report 1A5R
G-1
S0
M1
S2
D3
Q4
E5
A6
K7
P8
S9
T10
E11
D12
L13
G14
D15
K16
K17
E18
G19
E20
Y21
I22
K23
L24
K25
V26
I27
G28
Q29
D30
S31
S32
E33
I34
H35
F36
K37
V38
K39
M40
T41
T42
H43
L44
K45
K46
L47
K48
E49
S50
Y51
C52
Q53
R54
Q55
G56
V57
P58
M59
N60
S61
L62
R63
F64
L65
F66
E67
G68
Q69
R70
I71
A72
D73
N74
H75
T76
P77
K78
E79
L80
G81
M82
E83
E84
E85
D86
V87
I88
E89
V90
Y91
Q92
E93
Q94
T95
G96
G97
H98
S99
T100
V101
4.2.3 Score per residue for model 3
• Molecule 1: SUMO-1
Chain A:
G-1
S0
M1
S2
D3
Q4
E5
A6
K7
P8
S9
T10
E11
D12
L13
G14
D15
K16
K17
E18
G19
E20
Y21
I22
K23
L24
K25
V26
I27
D30
S31
S32
E33
I34
H35
F36
K37
V38
K39
M40
T41
T42
H43
L44
K45
K46
L47
K48
E49
S50
Y51
C52
Q53
R54
Q55
G56
V57
P58
S61
L62
R63
F64
L65
F66
E67
G68
Q69
R70
I71
A72
D73
N74
H75
T76
P77
K78
E79
L80
E83
E84
E85
D86
V87
I88
E89
V90
E93
Q94
T95
G96
G97
H98
S99
T100
V101
4.2.4 Score per residue for model 4
• Molecule 1: SUMO-1
Chain A:
G-1
S0
M1
S2
D3
Q4
E5
A6
K7
P8
S9
T10
E11
D12
L13
G14
D15
K16
K17
E18
G19
E20
Y21
I22
K23
L24
K25
V26
I27
D30
S31
S32
E33
I34
H35
F36
K37
V38
K39
M40
T41
T42
H43
L44
K45
K46
L47
K48
E49
S50
Y51
C52
Q53
R54
Q55
G56
V57
P58
M59
N60
S61
L62
R63
F64
L65
F66
E67
G68
Q69
R70
I71
A72
D73
N74
H75
T76
P77
K78
E79
L80
G81
M82
E83
E84
E85
D86
V87
I88
E89
V90
Y91
Q92
E93
Q94
T95
G96
G97
H98
S99
T100
V101
4.2.5 Score per residue for model 5
• Molecule 1: SUMO-1
Chain A:
G-1
S0
M1
S2
D3
Q4
E5
A6
K7
P8
S9
T10
E11
D12
L13
G14
D15
K16
K17
E18
G19
E20
Y21
I22
K23
L24
K25
V26
D30
S31
S32
E33
I34
H35
F36
K37
V38
K39
M40
T41
T42
H43
L44
K45
K46
L47
K48
E49
S50
Y51
C52
Q53
R54
Q55
G56
V57
P58
M59
N60
S61
L62
R63
F64
L65
F66
E67
G68
Q69
R70
I71
A72
D73
N74
H75
T76
P77
L80
E83
E84
E85
D86
V87
I88
E89
V90
Y91
Q92
E93
Q94
T95
G96
G97
H98
S99
T100
V101
4.2.6 Score per residue for model 6
• Molecule 1: SUMO-1
Page 7 Full wwPDB NMR Structure Validation Report 1A5R
Chain A:
G-1
S0
M1
S2
D3
Q4
E5
A6
K7
P8
S9
T10
E11
D12
L13
G14
D15
K16
K17
E18
G19
E20
Y21
I22
K23
L24
K25
V26
I27
D30
S31
S32
E33
I34
H35
F36
K37
V38
K39
M40
T41
T42
H43
L44
K45
K46
L47
K48
E49
S50
Y51
C52
Q53
R54
Q55
G56
V57
P58
M59
N60
S61
L62
R63
F64
L65
F66
E67
G68
Q69
R70
I71
A72
D73
N74
H75
T76
P77
K78
E79
L80
E83
E84
E85
D86
V87
I88
E89
V90
Y91
Q92
E93
Q94
T95
G96
G97
H98
S99
T100
V101
4.2.7 Score per residue for model 7
• Molecule 1: SUMO-1
Chain A:
G-1
S0
M1
S2
D3
Q4
E5
A6
K7
P8
S9
T10
E11
D12
L13
G14
D15
K16
K17
E18
G19
E20
Y21
I22
K23
L24
K25
V26
I27
G28
Q29
D30
S31
S32
E33
I34
H35
F36
K37
V38
K39
M40
T41
T42
H43
L44
K45
K46
L47
K48
E49
S50
Y51
C52
Q53
R54
Q55
G56
V57
P58
M59
N60
S61
L62
R63
F64
L65
F66
E67
G68
Q69
R70
I71
A72
D73
N74
H75
T76
P77
K78
E79
L80
G81
M82
E83
E84
E85
D86
V87
I88
E89
V90
Y91
Q92
E93
Q94
T95
G96
G97
H98
S99
T100
V101
4.2.8 Score per residue for model 8
• Molecule 1: SUMO-1
Chain A:
G-1
S0
M1
S2
D3
Q4
E5
A6
K7
P8
S9
T10
E11
D12
L13
G14
D15
K16
K17
E18
G19
E20
Y21
I22
K23
L24
K25
V26
I27
D30
S31
S32
E33
I34
H35
F36
K37
V38
K39
M40
T41
T42
H43
L44
K45
K46
L47
K48
E49
S50
Y51
C52
G56
V57
P58
M59
N60
S61
L62
R63
F64
L65
F66
E67
G68
Q69
R70
I71
A72
D73
N74
H75
T76
P77
K78
E79
L80
G81
M82
E83
E84
E85
D86
V87
I88
E89
V90
Y91
Q92
E93
Q94
T95
G96
G97
H98
S99
T100
V101
4.2.9 Score per residue for model 9
• Molecule 1: SUMO-1
Chain A:
G-1
S0
M1
S2
D3
Q4
E5
A6
K7
P8
S9
T10
E11
D12
L13
G14
D15
K16
K17
E18
G19
E20
Y21
I22
K23
L24
K25
V26
Q29
D30
S31
S32
E33
I34
H35
F36
K37
V38
K39
M40
T41
T42
H43
L44
K45
K46
L47
K48
E49
S50
Y51
C52
Q53
R54
Q55
G56
V57
P58
M59
N60
S61
L62
R63
F64
L65
F66
E67
G68
Q69
R70
I71
A72
D73
N74
H75
T76
P77
K78
E79
L80
E83
E84
E85
D86
V87
I88
E89
V90
Y91
Q92
E93
Q94
T95
G96
G97
H98
S99
T100
V101
Page 8 Full wwPDB NMR Structure Validation Report 1A5R
4.2.10 Score per residue for model 10
• Molecule 1: SUMO-1
Chain A:
G-1
S0
M1
S2
D3
Q4
E5
A6
K7
P8
S9
T10
E11
D12
L13
G14
D15
K16
K17
E18
G19
E20
Y21
I22
K23
L24
K25
V26
I27
G28
Q29
D30
S31
S32
E33
I34
H35
F36
K37
V38
K39
M40
T41
T42
H43
L44
K45
K46
L47
K48
E49
C52
Q53
R54
Q55
G56
V57
P58
M59
N60
S61
L62
R63
F64
L65
F66
E67
G68
Q69
R70
I71
A72
D73
N74
H75
T76
P77
K78
E79
L80
E83
E84
E85
D86
V87
I88
E89
V90
Y91
Q92
E93
Q94
T95
G96
G97
H98
S99
T100
V101
Page 9 Full wwPDB NMR Structure Validation Report 1A5R
5 Re�nement protocol and experimental data overview iO
The models were re�ned using the following method: simulated annealing.
Of the 30 calculated structures, 10 were deposited, based on the following criterion: ENERGY.
The following table shows the software used for structure solution, optimisation and re�nement.
Software name Classi�cation VersionX-PLOR re�nement 3.851NDEE structure solutionX-PLOR 3.851 PRE-RELEASE VERSION structure solution VERSION
No chemical shift data was provided. No validations of the models with respect to experimentalNMR restraints is performed at this time.
Page 10 Full wwPDB NMR Structure Validation Report 1A5R
6 Model quality iO
6.1 Standard geometry iO
There are no covalent bond-length or bond-angle outliers.
Chiral center outliers are detected by calculating the chiral volume of a chiral center and verifyingif the center is modelled as a planar moiety or with the opposite hand. A planarity outlier isdetected by checking planarity of atoms in a peptide group, atoms in a mainchain group or atomsof a sidechain that are expected to be planar.
Mol Chain Chirality Planarity1 A 0.0±0.0 2.5±0.5All All 0 25
There are no bond-length outliers.
There are no bond-angle outliers.
There are no chirality outliers.
All unique planar outliers are listed below. They are sorted by the frequency of occurrence in theensemble.
Mol Chain Res Type Group Models (Total)1 A 70 ARG Sidechain 101 A 63 ARG Sidechain 81 A 54 ARG Sidechain 7
6.2 Too-close contacts iO
In the following table, the Non-H and H(model) columns list the number of non-hydrogen atomsand hydrogen atoms in each chain respectively. The H(added) column lists the number of hydrogenatoms added and optimized by MolProbity. The Clashes column lists the number of clashesaveraged over the ensemble.
Mol Chain Non-H H(model) H(added) Clashes1 A 594 600 600 129±6All All 5940 6000 6000 1294
The all-atom clashscore is de�ned as the number of clashes found per 1000 atoms (includinghydrogen atoms). The all-atom clashscore for this structure is 108.
All unique clashes are listed below, sorted by their clash magnitude.
Page 11 Full wwPDB NMR Structure Validation Report 1A5R
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:38:VAL:HG21 1:A:47:LEU:HD23 1.05 1.19 1 91:A:44:LEU:HD23 1:A:80:LEU:HD21 0.98 1.34 9 21:A:38:VAL:HG21 1:A:47:LEU:CD2 0.97 1.90 4 81:A:75:HIS:O 1:A:80:LEU:HD22 0.93 1.62 5 6
1:A:38:VAL:CG2 1:A:47:LEU:HD12 0.93 1.94 2 11:A:24:LEU:HD13 1:A:47:LEU:HD22 0.90 1.43 2 11:A:44:LEU:HD23 1:A:80:LEU:HD11 0.90 1.42 6 71:A:65:LEU:HD11 1:A:68:GLY:O 0.89 1.68 9 71:A:24:LEU:HD21 1:A:88:ILE:HD13 0.89 1.43 3 61:A:24:LEU:HD13 1:A:47:LEU:HG 0.89 1.43 6 81:A:38:VAL:CG2 1:A:47:LEU:HD23 0.88 1.96 4 81:A:24:LEU:HD11 1:A:88:ILE:CD1 0.87 1.99 6 61:A:65:LEU:HD11 1:A:68:GLY:C 0.87 1.89 5 71:A:24:LEU:HD11 1:A:88:ILE:HD11 0.86 1.45 2 71:A:66:PHE:HB3 1:A:71:ILE:HG21 0.84 1.45 4 71:A:65:LEU:HD21 1:A:68:GLY:C 0.84 1.93 6 31:A:22:ILE:HD13 1:A:38:VAL:O 0.83 1.72 1 31:A:65:LEU:HD21 1:A:68:GLY:O 0.83 1.74 8 41:A:38:VAL:HG21 1:A:47:LEU:HD12 0.83 1.49 2 11:A:44:LEU:N 1:A:80:LEU:HD21 0.82 1.90 5 61:A:63:ARG:O 1:A:90:VAL:HG12 0.82 1.73 1 101:A:79:GLU:C 1:A:80:LEU:HD12 0.82 1.96 2 71:A:34:ILE:O 1:A:34:ILE:HD12 0.81 1.76 6 11:A:75:HIS:O 1:A:80:LEU:HD13 0.80 1.76 1 41:A:33:GLU:O 1:A:34:ILE:HD13 0.80 1.75 1 5
1:A:26:VAL:HG22 1:A:34:ILE:HD11 0.80 1.51 2 21:A:22:ILE:HG22 1:A:83:GLU:C 0.80 1.96 4 31:A:38:VAL:HG11 1:A:47:LEU:HD23 0.80 1.54 3 11:A:27:ILE:HG22 1:A:33:GLU:HA 0.80 1.53 8 31:A:52:CYS:SG 1:A:57:VAL:HG12 0.80 2.17 2 2
1:A:24:LEU:HD23 1:A:25:LYS:N 0.79 1.93 2 21:A:56:GLY:O 1:A:62:LEU:HD13 0.79 1.77 2 3
1:A:34:ILE:HG22 1:A:36:PHE:CD1 0.79 2.13 7 41:A:22:ILE:HG22 1:A:83:GLU:O 0.78 1.79 1 81:A:58:PRO:HA 1:A:62:LEU:HD13 0.78 1.56 5 11:A:26:VAL:HG12 1:A:88:ILE:HB 0.77 1.55 6 81:A:24:LEU:HD21 1:A:88:ILE:CD1 0.77 2.10 2 51:A:76:THR:HA 1:A:80:LEU:HB2 0.77 1.57 7 101:A:24:LEU:HD13 1:A:86:ASP:HB3 0.76 1.56 1 11:A:24:LEU:HD22 1:A:47:LEU:HD11 0.74 1.57 10 71:A:65:LEU:HD12 1:A:69:GLN:O 0.74 1.82 5 51:A:65:LEU:HD11 1:A:68:GLY:HA2 0.74 1.58 6 3
Continued on next page...
Page 12 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:87:VAL:C 1:A:88:ILE:HD12 0.74 2.01 7 11:A:66:PHE:CB 1:A:71:ILE:HG21 0.73 2.13 3 71:A:24:LEU:HD12 1:A:86:ASP:OD2 0.73 1.82 6 61:A:34:ILE:HG22 1:A:36:PHE:CE1 0.73 2.19 1 11:A:62:LEU:HD12 1:A:62:LEU:N 0.72 1.99 5 51:A:24:LEU:CD2 1:A:47:LEU:HD11 0.72 2.15 10 31:A:62:LEU:HD11 1:A:64:PHE:CZ 0.71 2.20 7 11:A:64:PHE:CD1 1:A:90:VAL:HG13 0.70 2.21 3 51:A:71:ILE:HD12 1:A:71:ILE:C 0.70 2.07 4 11:A:24:LEU:HD22 1:A:47:LEU:CD1 0.70 2.14 10 31:A:65:LEU:O 1:A:88:ILE:HG23 0.70 1.85 9 4
1:A:66:PHE:CE2 1:A:88:ILE:CG1 0.69 2.75 2 51:A:26:VAL:CG2 1:A:51:TYR:CE1 0.69 2.75 8 11:A:24:LEU:HD21 1:A:88:ILE:HD12 0.69 1.64 2 21:A:33:GLU:CG 1:A:35:HIS:HE2 0.69 2.00 10 41:A:76:THR:HA 1:A:80:LEU:HD12 0.69 1.65 7 11:A:62:LEU:HD23 1:A:92:GLN:HG2 0.68 1.66 7 11:A:69:GLN:O 1:A:71:ILE:HG23 0.68 1.88 9 101:A:36:PHE:CE2 1:A:38:VAL:CG2 0.67 2.78 10 11:A:56:GLY:O 1:A:62:LEU:HD22 0.67 1.90 4 31:A:33:GLU:C 1:A:34:ILE:HD13 0.67 2.10 3 21:A:61:SER:C 1:A:62:LEU:HD12 0.66 2.11 5 3
1:A:24:LEU:HD12 1:A:86:ASP:CG 0.66 2.10 10 31:A:24:LEU:HD13 1:A:86:ASP:CB 0.66 2.19 1 11:A:80:LEU:HD12 1:A:80:LEU:N 0.66 2.05 3 61:A:24:LEU:HD21 1:A:26:VAL:CG1 0.66 2.21 8 61:A:66:PHE:CB 1:A:71:ILE:CD1 0.66 2.74 10 31:A:45:LYS:O 1:A:49:GLU:CB 0.66 2.44 4 61:A:56:GLY:C 1:A:62:LEU:HD13 0.66 2.10 2 11:A:62:LEU:N 1:A:62:LEU:HD12 0.65 2.04 10 2
1:A:62:LEU:HD12 1:A:92:GLN:HG2 0.65 1.68 8 11:A:44:LEU:HD12 1:A:48:LYS:HG2 0.65 1.66 7 21:A:66:PHE:CE2 1:A:88:ILE:HG12 0.65 2.25 2 31:A:47:LEU:HD13 1:A:47:LEU:C 0.65 2.11 6 11:A:33:GLU:CG 1:A:35:HIS:NE2 0.65 2.59 8 91:A:52:CYS:O 1:A:56:GLY:N 0.65 2.30 2 91:A:33:GLU:CD 1:A:35:HIS:HE2 0.64 1.95 8 41:A:24:LEU:C 1:A:24:LEU:HD23 0.64 2.12 2 21:A:66:PHE:CB 1:A:71:ILE:HD13 0.64 2.22 9 61:A:76:THR:CB 1:A:77:PRO:CD 0.64 2.76 5 31:A:42:THR:O 1:A:43:HIS:CD2 0.64 2.51 3 3
Continued on next page...
Page 13 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:64:PHE:CD1 1:A:90:VAL:CG1 0.63 2.81 7 51:A:36:PHE:CE2 1:A:47:LEU:HD11 0.63 2.28 2 11:A:57:VAL:HG23 1:A:59:MET:HG2 0.63 1.69 8 11:A:76:THR:N 1:A:77:PRO:CD 0.63 2.60 7 6
1:A:62:LEU:HD22 1:A:63:ARG:N 0.63 2.07 7 11:A:24:LEU:HD11 1:A:88:ILE:HD12 0.63 1.69 1 11:A:24:LEU:HD22 1:A:47:LEU:CG 0.63 2.24 10 21:A:26:VAL:CG2 1:A:51:TYR:CZ 0.63 2.81 8 21:A:66:PHE:CD2 1:A:88:ILE:CG1 0.63 2.81 7 71:A:38:VAL:CB 1:A:47:LEU:HD23 0.62 2.22 8 3
1:A:47:LEU:HD13 1:A:48:LYS:N 0.62 2.09 5 31:A:71:ILE:HD12 1:A:75:HIS:NE2 0.62 2.09 9 21:A:75:HIS:NE2 1:A:80:LEU:HD21 0.62 2.10 7 11:A:76:THR:CA 1:A:80:LEU:HD12 0.62 2.24 7 11:A:65:LEU:HD11 1:A:68:GLY:CA 0.62 2.24 6 31:A:36:PHE:CE2 1:A:38:VAL:HG22 0.62 2.30 10 11:A:66:PHE:CZ 1:A:86:ASP:OD1 0.62 2.52 5 31:A:47:LEU:O 1:A:47:LEU:HD22 0.62 1.94 1 21:A:22:ILE:O 1:A:37:LYS:HA 0.62 1.95 4 10
1:A:66:PHE:CD2 1:A:88:ILE:HG12 0.61 2.30 7 71:A:33:GLU:CG 1:A:35:HIS:CD2 0.61 2.84 1 31:A:58:PRO:HG3 1:A:64:PHE:CE2 0.61 2.29 3 31:A:22:ILE:HG22 1:A:83:GLU:CA 0.61 2.25 4 11:A:22:ILE:CD1 1:A:40:MET:CG 0.61 2.78 2 41:A:75:HIS:CD2 1:A:80:LEU:HD13 0.61 2.30 4 21:A:57:VAL:O 1:A:60:ASN:ND2 0.61 2.34 6 3
1:A:44:LEU:HD22 1:A:71:ILE:HD11 0.61 1.71 9 11:A:36:PHE:CZ 1:A:47:LEU:HD21 0.60 2.31 1 41:A:76:THR:HB 1:A:77:PRO:HD3 0.60 1.72 3 101:A:33:GLU:HG2 1:A:35:HIS:CD2 0.60 2.32 1 71:A:39:LYS:O 1:A:40:MET:HE1 0.60 1.97 3 11:A:52:CYS:SG 1:A:64:PHE:CZ 0.60 2.95 4 4
1:A:38:VAL:HG12 1:A:39:LYS:N 0.60 2.11 2 61:A:43:HIS:CG 1:A:74:ASN:HA 0.60 2.30 6 91:A:71:ILE:C 1:A:71:ILE:CD1 0.60 2.69 4 1
1:A:66:PHE:HB3 1:A:71:ILE:HD13 0.60 1.72 9 31:A:76:THR:CB 1:A:77:PRO:HD3 0.60 2.26 5 41:A:62:LEU:CD1 1:A:64:PHE:CE2 0.60 2.84 7 11:A:48:LYS:O 1:A:52:CYS:N 0.60 2.34 5 61:A:87:VAL:O 1:A:87:VAL:HG13 0.59 1.96 9 3
1:A:66:PHE:HB2 1:A:71:ILE:HG12 0.59 1.74 10 7Continued on next page...
Page 14 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:63:ARG:O 1:A:90:VAL:HA 0.59 1.96 4 91:A:49:GLU:HG3 1:A:50:SER:N 0.59 2.13 3 61:A:76:THR:HA 1:A:80:LEU:CB 0.59 2.28 9 41:A:48:LYS:HB2 1:A:64:PHE:CZ 0.59 2.33 3 31:A:44:LEU:HD21 1:A:71:ILE:HD12 0.58 1.75 1 31:A:24:LEU:HD23 1:A:24:LEU:C 0.58 2.18 9 41:A:58:PRO:CB 1:A:62:LEU:HB2 0.58 2.28 5 11:A:47:LEU:C 1:A:47:LEU:HD13 0.58 2.18 5 3
1:A:62:LEU:CD1 1:A:62:LEU:N 0.58 2.67 5 31:A:65:LEU:C 1:A:65:LEU:HD13 0.58 2.18 6 21:A:66:PHE:CG 1:A:71:ILE:HD13 0.57 2.34 3 41:A:43:HIS:CB 1:A:73:ASP:O 0.57 2.52 1 101:A:22:ILE:HD11 1:A:40:MET:CG 0.57 2.29 2 11:A:91:TYR:CD1 1:A:91:TYR:N 0.57 2.72 5 21:A:88:ILE:HD12 1:A:88:ILE:N 0.57 2.13 7 11:A:39:LYS:O 1:A:39:LYS:HG3 0.57 1.99 3 4
1:A:66:PHE:CD1 1:A:88:ILE:HG13 0.57 2.35 4 21:A:66:PHE:CE1 1:A:86:ASP:OD1 0.57 2.57 4 11:A:64:PHE:HD2 1:A:88:ILE:HG21 0.57 1.60 6 11:A:24:LEU:CD2 1:A:47:LEU:CD1 0.57 2.82 10 11:A:22:ILE:CD1 1:A:40:MET:HG3 0.57 2.29 9 21:A:65:LEU:CB 1:A:89:GLU:O 0.57 2.52 7 21:A:62:LEU:HD23 1:A:92:GLN:CG 0.57 2.30 7 11:A:52:CYS:SG 1:A:58:PRO:CD 0.57 2.92 9 21:A:76:THR:N 1:A:77:PRO:HD2 0.57 2.15 7 6
1:A:36:PHE:CD1 1:A:36:PHE:N 0.57 2.73 2 41:A:65:LEU:HB3 1:A:89:GLU:O 0.57 1.99 7 81:A:72:ALA:O 1:A:75:HIS:NE2 0.57 2.37 3 3
1:A:42:THR:OG1 1:A:43:HIS:N 0.57 2.37 9 51:A:42:THR:HG23 1:A:43:HIS:H 0.57 1.60 3 11:A:47:LEU:C 1:A:47:LEU:HD22 0.56 2.20 1 21:A:48:LYS:HB2 1:A:64:PHE:CE2 0.56 2.35 1 31:A:80:LEU:N 1:A:80:LEU:CD1 0.56 2.68 1 21:A:76:THR:O 1:A:80:LEU:HB2 0.56 2.00 3 9
1:A:51:TYR:CE1 1:A:55:GLN:NE2 0.56 2.73 7 31:A:24:LEU:CD2 1:A:26:VAL:HG13 0.56 2.31 8 41:A:33:GLU:OE2 1:A:35:HIS:CD2 0.56 2.59 4 21:A:22:ILE:HG22 1:A:83:GLU:HA 0.56 1.75 4 21:A:24:LEU:HD12 1:A:86:ASP:CB 0.56 2.30 10 21:A:45:LYS:HA 1:A:48:LYS:CE 0.56 2.30 2 31:A:44:LEU:N 1:A:80:LEU:CD2 0.56 2.69 6 2
Continued on next page...
Page 15 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:75:HIS:CE1 1:A:80:LEU:CD1 0.56 2.88 5 41:A:87:VAL:HG13 1:A:87:VAL:O 0.56 2.01 3 41:A:66:PHE:CD1 1:A:88:ILE:CG1 0.56 2.88 4 21:A:44:LEU:CD2 1:A:71:ILE:HD11 0.56 2.31 9 11:A:65:LEU:HD13 1:A:66:PHE:N 0.56 2.16 4 21:A:65:LEU:HD12 1:A:69:GLN:C 0.56 2.22 2 51:A:66:PHE:CD2 1:A:88:ILE:HG13 0.56 2.36 5 21:A:65:LEU:HD13 1:A:65:LEU:C 0.56 2.22 8 21:A:22:ILE:CD1 1:A:40:MET:CB 0.55 2.84 5 11:A:24:LEU:HD13 1:A:86:ASP:C 0.55 2.22 1 11:A:30:ASP:O 1:A:31:SER:HB2 0.55 2.02 10 7
1:A:27:ILE:HG22 1:A:33:GLU:CB 0.55 2.32 6 11:A:62:LEU:CD1 1:A:92:GLN:HG2 0.55 2.31 8 11:A:36:PHE:N 1:A:36:PHE:CD1 0.55 2.74 1 51:A:49:GLU:CG 1:A:50:SER:N 0.55 2.70 2 61:A:27:ILE:O 1:A:90:VAL:HG23 0.55 2.00 4 1
1:A:63:ARG:CZ 1:A:70:ARG:CG 0.55 2.85 6 11:A:48:LYS:O 1:A:52:CYS:SG 0.55 2.65 5 6
1:A:65:LEU:HD22 1:A:69:GLN:O 0.55 2.02 6 31:A:52:CYS:SG 1:A:53:GLN:N 0.54 2.80 2 31:A:80:LEU:CD1 1:A:80:LEU:N 0.54 2.70 2 31:A:65:LEU:CD2 1:A:69:GLN:C 0.54 2.75 6 31:A:24:LEU:CD2 1:A:26:VAL:CG1 0.54 2.85 8 31:A:34:ILE:C 1:A:34:ILE:HD12 0.54 2.23 6 1
1:A:65:LEU:CD1 1:A:69:GLN:C 0.54 2.76 2 61:A:34:ILE:HG13 1:A:51:TYR:CE2 0.54 2.38 9 11:A:64:PHE:CE1 1:A:90:VAL:HG11 0.54 2.37 1 21:A:36:PHE:CE2 1:A:47:LEU:CD1 0.54 2.90 2 11:A:52:CYS:HB2 1:A:58:PRO:HD3 0.54 1.78 3 21:A:75:HIS:ND1 1:A:80:LEU:HD13 0.54 2.16 8 41:A:28:GLY:HA2 1:A:90:VAL:O 0.54 2.03 10 41:A:75:HIS:CD2 1:A:80:LEU:HD11 0.54 2.38 7 11:A:36:PHE:CE1 1:A:47:LEU:HD21 0.54 2.38 6 11:A:40:MET:CE 1:A:47:LEU:CB 0.54 2.85 8 11:A:22:ILE:HD12 1:A:40:MET:CG 0.54 2.33 1 21:A:24:LEU:CD1 1:A:47:LEU:HD22 0.54 2.29 2 11:A:33:GLU:OE2 1:A:35:HIS:NE2 0.54 2.40 10 41:A:64:PHE:CD2 1:A:90:VAL:CG1 0.54 2.91 10 21:A:44:LEU:H 1:A:80:LEU:HD21 0.54 1.63 4 51:A:34:ILE:CG2 1:A:36:PHE:CD1 0.54 2.91 10 21:A:26:VAL:HG23 1:A:51:TYR:CZ 0.54 2.37 8 1
Continued on next page...
Page 16 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:27:ILE:HG22 1:A:33:GLU:HG3 0.53 1.79 6 11:A:27:ILE:HG22 1:A:33:GLU:CG 0.53 2.33 6 11:A:38:VAL:HG12 1:A:39:LYS:H 0.53 1.63 10 51:A:33:GLU:HG3 1:A:35:HIS:NE2 0.53 2.18 4 51:A:21:TYR:HA 1:A:38:VAL:O 0.53 2.02 1 41:A:65:LEU:HD22 1:A:69:GLN:C 0.53 2.23 8 41:A:66:PHE:CE2 1:A:88:ILE:HD11 0.53 2.38 10 31:A:48:LYS:HD3 1:A:64:PHE:CE2 0.53 2.39 2 21:A:52:CYS:SG 1:A:64:PHE:CE1 0.53 3.02 8 11:A:66:PHE:HB2 1:A:71:ILE:HD13 0.53 1.80 3 41:A:87:VAL:HG22 1:A:89:GLU:OE2 0.53 2.03 5 11:A:52:CYS:HB3 1:A:58:PRO:HD2 0.53 1.80 5 11:A:66:PHE:CD2 1:A:71:ILE:HD13 0.53 2.38 6 21:A:26:VAL:HG21 1:A:51:TYR:CE2 0.53 2.39 5 41:A:39:LYS:O 1:A:40:MET:CE 0.53 2.57 3 11:A:22:ILE:O 1:A:37:LYS:CA 0.53 2.57 4 10
1:A:34:ILE:HG13 1:A:51:TYR:CE1 0.53 2.39 4 21:A:58:PRO:O 1:A:62:LEU:N 0.53 2.39 5 11:A:25:LYS:HB2 1:A:35:HIS:ND1 0.52 2.19 5 81:A:71:ILE:HD12 1:A:71:ILE:O 0.52 2.02 4 11:A:65:LEU:HD22 1:A:91:TYR:CE2 0.52 2.38 9 11:A:40:MET:SD 1:A:80:LEU:O 0.52 2.67 5 11:A:64:PHE:CE1 1:A:90:VAL:CG1 0.52 2.93 1 11:A:45:LYS:HB3 1:A:73:ASP:HB2 0.52 1.81 4 31:A:38:VAL:HG11 1:A:47:LEU:HA 0.52 1.79 8 11:A:33:GLU:HG3 1:A:35:HIS:HE2 0.52 1.64 10 11:A:63:ARG:O 1:A:90:VAL:CG1 0.52 2.54 1 6
1:A:58:PRO:HG3 1:A:64:PHE:CE1 0.52 2.39 1 11:A:45:LYS:O 1:A:49:GLU:HB3 0.52 2.05 4 61:A:43:HIS:CD2 1:A:74:ASN:C 0.52 2.82 4 11:A:80:LEU:N 1:A:80:LEU:HD12 0.52 2.18 4 21:A:44:LEU:HG 1:A:73:ASP:HA 0.52 1.82 7 11:A:75:HIS:O 1:A:75:HIS:ND1 0.52 2.42 8 1
1:A:66:PHE:HB2 1:A:71:ILE:CD1 0.52 2.35 6 61:A:42:THR:C 1:A:43:HIS:CG 0.52 2.82 9 2
1:A:65:LEU:HD21 1:A:69:GLN:N 0.52 2.19 6 21:A:83:GLU:O 1:A:84:GLU:CG 0.52 2.57 5 31:A:83:GLU:O 1:A:84:GLU:HB2 0.52 2.05 6 1
1:A:65:LEU:HD11 1:A:69:GLN:N 0.52 2.20 5 41:A:21:TYR:CE1 1:A:39:LYS:HB3 0.52 2.40 2 21:A:44:LEU:HD21 1:A:71:ILE:CD1 0.52 2.35 8 1
Continued on next page...
Page 17 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:22:ILE:HD11 1:A:40:MET:HG2 0.52 1.80 2 21:A:24:LEU:HD13 1:A:47:LEU:CG 0.52 2.25 6 21:A:44:LEU:HD22 1:A:66:PHE:CE2 0.52 2.40 7 11:A:60:ASN:OD1 1:A:61:SER:N 0.52 2.43 8 21:A:42:THR:HG23 1:A:43:HIS:N 0.52 2.20 5 11:A:52:CYS:CB 1:A:58:PRO:HD2 0.52 2.35 5 11:A:43:HIS:CA 1:A:73:ASP:O 0.51 2.58 7 11:A:66:PHE:CE1 1:A:88:ILE:HG13 0.51 2.41 4 11:A:65:LEU:HD22 1:A:91:TYR:HE2 0.51 1.66 9 11:A:82:MET:CE 1:A:85:GLU:O 0.51 2.59 1 11:A:33:GLU:HG2 1:A:35:HIS:NE2 0.51 2.20 9 21:A:22:ILE:CG2 1:A:83:GLU:O 0.51 2.57 9 11:A:62:LEU:N 1:A:62:LEU:CD1 0.51 2.74 10 11:A:22:ILE:CD1 1:A:40:MET:HB2 0.51 2.34 5 11:A:26:VAL:HG22 1:A:34:ILE:CD1 0.51 2.32 2 21:A:34:ILE:O 1:A:34:ILE:CD1 0.51 2.56 6 1
1:A:22:ILE:CD1 1:A:38:VAL:O 0.51 2.58 6 11:A:52:CYS:SG 1:A:58:PRO:CG 0.51 2.99 9 11:A:66:PHE:CE1 1:A:88:ILE:HD11 0.51 2.41 3 11:A:45:LYS:HG3 1:A:46:LYS:N 0.51 2.21 10 51:A:87:VAL:O 1:A:87:VAL:CG1 0.51 2.59 9 3
1:A:52:CYS:HB3 1:A:58:PRO:HD3 0.51 1.82 6 31:A:63:ARG:CG 1:A:70:ARG:HD3 0.51 2.36 7 11:A:52:CYS:SG 1:A:58:PRO:HD3 0.50 2.46 1 61:A:45:LYS:HA 1:A:48:LYS:HE3 0.50 1.84 2 1
1:A:26:VAL:HG21 1:A:51:TYR:CE1 0.50 2.40 8 11:A:61:SER:OG 1:A:62:LEU:HD12 0.50 2.05 3 11:A:43:HIS:HB3 1:A:73:ASP:O 0.50 2.06 8 61:A:75:HIS:O 1:A:75:HIS:CG 0.50 2.64 7 1
1:A:40:MET:HE3 1:A:47:LEU:CB 0.50 2.37 8 11:A:62:LEU:HD11 1:A:64:PHE:CE2 0.50 2.40 7 11:A:25:LYS:CB 1:A:35:HIS:ND1 0.50 2.75 5 11:A:42:THR:O 1:A:76:THR:CG2 0.50 2.59 5 11:A:64:PHE:CZ 1:A:90:VAL:HG11 0.50 2.41 6 21:A:27:ILE:CG2 1:A:33:GLU:HG3 0.50 2.37 6 11:A:64:PHE:CG 1:A:90:VAL:CG1 0.50 2.94 6 11:A:65:LEU:CD2 1:A:68:GLY:O 0.50 2.54 7 11:A:51:TYR:O 1:A:55:GLN:CG 0.50 2.60 5 11:A:38:VAL:CG1 1:A:47:LEU:HD23 0.50 2.33 3 11:A:30:ASP:O 1:A:31:SER:HB3 0.50 2.07 5 3
1:A:30:ASP:OD1 1:A:32:SER:OG 0.50 2.29 8 3Continued on next page...
Page 18 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:54:ARG:HG3 1:A:55:GLN:HG3 0.50 1.84 3 11:A:76:THR:HA 1:A:80:LEU:CD1 0.50 2.35 7 11:A:22:ILE:HD13 1:A:40:MET:CG 0.50 2.37 9 11:A:67:GLU:HG3 1:A:68:GLY:N 0.50 2.22 9 21:A:40:MET:HE3 1:A:47:LEU:N 0.50 2.22 3 11:A:23:LYS:CA 1:A:37:LYS:HG2 0.50 2.37 7 41:A:42:THR:O 1:A:76:THR:OG1 0.50 2.30 8 6
1:A:42:THR:OG1 1:A:43:HIS:ND1 0.50 2.45 6 11:A:76:THR:H 1:A:77:PRO:CD 0.49 2.20 4 21:A:50:SER:O 1:A:54:ARG:CB 0.49 2.60 4 1
1:A:78:LYS:HG2 1:A:79:GLU:HG2 0.49 1.84 3 11:A:82:MET:SD 1:A:85:GLU:O 0.49 2.70 4 31:A:66:PHE:CE1 1:A:88:ILE:CG1 0.49 2.95 3 11:A:44:LEU:CB 1:A:80:LEU:HD21 0.49 2.38 6 11:A:24:LEU:HD12 1:A:86:ASP:HB3 0.49 1.84 10 11:A:58:PRO:CA 1:A:62:LEU:HB2 0.49 2.37 5 11:A:58:PRO:CB 1:A:62:LEU:O 0.49 2.60 9 21:A:36:PHE:C 1:A:36:PHE:CD1 0.49 2.85 9 31:A:60:ASN:CG 1:A:61:SER:N 0.49 2.66 9 21:A:23:LYS:HA 1:A:37:LYS:CG 0.49 2.38 7 21:A:75:HIS:HD2 1:A:80:LEU:HD13 0.49 1.68 9 11:A:23:LYS:HB3 1:A:84:GLU:O 0.49 2.07 1 61:A:44:LEU:CD2 1:A:75:HIS:NE2 0.49 2.76 7 21:A:60:ASN:ND2 1:A:61:SER:OG 0.49 2.45 7 11:A:48:LYS:HA 1:A:51:TYR:HB3 0.49 1.84 3 21:A:45:LYS:CG 1:A:46:LYS:N 0.49 2.75 6 31:A:76:THR:OG1 1:A:77:PRO:CD 0.49 2.61 5 11:A:25:LYS:HG3 1:A:25:LYS:O 0.49 2.07 4 31:A:45:LYS:O 1:A:49:GLU:HB2 0.49 2.08 10 4
1:A:58:PRO:HB3 1:A:62:LEU:O 0.49 2.07 8 31:A:52:CYS:O 1:A:56:GLY:C 0.49 2.51 7 51:A:40:MET:CE 1:A:44:LEU:HA 0.49 2.38 2 21:A:30:ASP:OD1 1:A:32:SER:N 0.49 2.45 6 11:A:45:LYS:HA 1:A:48:LYS:CG 0.49 2.37 7 21:A:43:HIS:CD2 1:A:74:ASN:HA 0.49 2.42 7 41:A:44:LEU:CD2 1:A:71:ILE:CD1 0.49 2.91 9 11:A:61:SER:CB 1:A:62:LEU:HD12 0.49 2.37 10 11:A:42:THR:O 1:A:76:THR:HG23 0.49 2.07 5 11:A:24:LEU:N 1:A:36:PHE:O 0.49 2.46 7 1
1:A:89:GLU:OE1 1:A:89:GLU:N 0.48 2.46 1 11:A:66:PHE:HB2 1:A:71:ILE:CG1 0.48 2.38 6 6
Continued on next page...
Page 19 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:34:ILE:CG2 1:A:36:PHE:CE1 0.48 2.96 1 21:A:44:LEU:CD2 1:A:80:LEU:HD21 0.48 2.22 9 11:A:42:THR:OG1 1:A:43:HIS:CE1 0.48 2.66 3 21:A:40:MET:CE 1:A:47:LEU:HB3 0.48 2.39 2 11:A:22:ILE:CG2 1:A:83:GLU:HA 0.48 2.39 4 11:A:26:VAL:CG1 1:A:88:ILE:HB 0.48 2.39 9 21:A:44:LEU:HG 1:A:73:ASP:CA 0.48 2.39 7 11:A:73:ASP:C 1:A:73:ASP:OD1 0.48 2.53 1 31:A:30:ASP:N 1:A:30:ASP:OD1 0.48 2.47 9 21:A:43:HIS:HA 1:A:73:ASP:O 0.48 2.08 7 11:A:38:VAL:CG2 1:A:47:LEU:CD2 0.48 2.84 8 11:A:34:ILE:HD12 1:A:36:PHE:CE1 0.48 2.43 2 21:A:75:HIS:CD2 1:A:80:LEU:CD1 0.48 2.97 4 11:A:61:SER:O 1:A:92:GLN:HA 0.48 2.09 8 21:A:45:LYS:HB3 1:A:73:ASP:OD2 0.48 2.09 8 11:A:24:LEU:HD12 1:A:25:LYS:N 0.47 2.23 1 11:A:25:LYS:HA 1:A:34:ILE:O 0.47 2.09 4 41:A:24:LEU:CD1 1:A:88:ILE:CD1 0.47 2.89 2 31:A:48:LYS:HE2 1:A:73:ASP:HB3 0.47 1.86 9 21:A:21:TYR:O 1:A:83:GLU:O 0.47 2.32 7 1
1:A:51:TYR:CD1 1:A:55:GLN:NE2 0.47 2.82 3 11:A:43:HIS:HA 1:A:80:LEU:CD2 0.47 2.39 4 11:A:69:GLN:O 1:A:71:ILE:CG2 0.47 2.61 9 11:A:78:LYS:HG2 1:A:79:GLU:HG3 0.47 1.86 4 11:A:44:LEU:HB3 1:A:80:LEU:HD21 0.47 1.86 6 11:A:38:VAL:HB 1:A:47:LEU:HD23 0.47 1.85 8 11:A:22:ILE:HA 1:A:83:GLU:O 0.47 2.09 1 11:A:34:ILE:CD1 1:A:36:PHE:CE1 0.47 2.97 5 21:A:49:GLU:HA 1:A:52:CYS:SG 0.47 2.49 3 21:A:30:ASP:OD2 1:A:92:GLN:OE1 0.47 2.32 6 11:A:44:LEU:CG 1:A:73:ASP:HA 0.47 2.40 7 11:A:52:CYS:SG 1:A:58:PRO:N 0.47 2.88 10 11:A:54:ARG:CG 1:A:55:GLN:N 0.47 2.78 5 11:A:83:GLU:CG 1:A:84:GLU:N 0.47 2.78 1 21:A:22:ILE:CD1 1:A:40:MET:HG2 0.47 2.39 7 41:A:45:LYS:O 1:A:49:GLU:CG 0.47 2.63 5 4
1:A:36:PHE:CE2 1:A:47:LEU:CD2 0.47 2.98 7 11:A:30:ASP:CG 1:A:32:SER:HG 0.47 2.13 8 11:A:30:ASP:O 1:A:31:SER:CB 0.47 2.62 3 41:A:43:HIS:HB2 1:A:73:ASP:O 0.47 2.09 6 31:A:66:PHE:HB3 1:A:71:ILE:CD1 0.47 2.39 7 1
Continued on next page...
Page 20 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:30:ASP:CG 1:A:32:SER:OG 0.47 2.53 2 31:A:60:ASN:ND2 1:A:60:ASN:C 0.47 2.67 2 21:A:47:LEU:HD22 1:A:47:LEU:O 0.47 2.10 7 21:A:52:CYS:SG 1:A:53:GLN:HG3 0.47 2.49 7 11:A:23:LYS:HA 1:A:37:LYS:HG2 0.47 1.86 7 81:A:75:HIS:CE1 1:A:80:LEU:HD11 0.47 2.45 6 21:A:24:LEU:HD13 1:A:47:LEU:CD2 0.46 2.31 2 11:A:25:LYS:CA 1:A:34:ILE:O 0.46 2.63 4 11:A:58:PRO:HA 1:A:62:LEU:O 0.46 2.10 4 21:A:52:CYS:HB2 1:A:57:VAL:HA 0.46 1.86 3 11:A:62:LEU:HD12 1:A:92:GLN:CG 0.46 2.37 8 11:A:22:ILE:HD13 1:A:40:MET:HG2 0.46 1.87 9 11:A:25:LYS:HD3 1:A:35:HIS:CE1 0.46 2.45 1 11:A:65:LEU:CD1 1:A:69:GLN:CA 0.46 2.93 10 31:A:40:MET:CE 1:A:46:LYS:HB2 0.46 2.40 3 11:A:30:ASP:OD1 1:A:32:SER:CB 0.46 2.64 6 11:A:56:GLY:O 1:A:58:PRO:N 0.46 2.48 5 1
1:A:62:LEU:HD21 1:A:90:VAL:HB 0.46 1.86 7 11:A:57:VAL:HG22 1:A:59:MET:H 0.46 1.70 1 31:A:24:LEU:C 1:A:24:LEU:CD2 0.46 2.83 2 11:A:25:LYS:HB2 1:A:34:ILE:O 0.46 2.11 4 11:A:56:GLY:O 1:A:57:VAL:C 0.46 2.52 5 21:A:75:HIS:O 1:A:80:LEU:CD1 0.46 2.62 3 21:A:25:LYS:O 1:A:25:LYS:CG 0.46 2.64 7 11:A:45:LYS:O 1:A:49:GLU:HG2 0.46 2.10 7 4
1:A:26:VAL:CG2 1:A:51:TYR:CE2 0.46 2.99 9 11:A:42:THR:C 1:A:76:THR:HG23 0.46 2.30 5 11:A:64:PHE:CE2 1:A:90:VAL:HG11 0.46 2.45 10 21:A:66:PHE:CD1 1:A:88:ILE:HG12 0.45 2.46 3 11:A:65:LEU:CD1 1:A:69:GLN:O 0.45 2.62 5 11:A:38:VAL:CG1 1:A:39:LYS:N 0.45 2.78 2 31:A:26:VAL:HA 1:A:88:ILE:O 0.45 2.12 7 41:A:30:ASP:OD1 1:A:30:ASP:C 0.45 2.54 6 31:A:34:ILE:HG13 1:A:51:TYR:OH 0.45 2.12 8 11:A:22:ILE:HD12 1:A:40:MET:HG3 0.45 1.87 1 11:A:66:PHE:CG 1:A:71:ILE:CD1 0.45 3.00 10 21:A:56:GLY:O 1:A:57:VAL:O 0.45 2.34 10 11:A:75:HIS:O 1:A:80:LEU:CD2 0.45 2.61 3 2
1:A:85:GLU:OE1 1:A:85:GLU:HA 0.45 2.12 2 11:A:62:LEU:HG 1:A:92:GLN:HG2 0.45 1.88 9 41:A:75:HIS:CE1 1:A:80:LEU:HD13 0.45 2.46 5 1
Continued on next page...
Page 21 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:27:ILE:HA 1:A:32:SER:O 0.45 2.11 7 21:A:62:LEU:CD1 1:A:64:PHE:CZ 0.45 2.98 7 11:A:67:GLU:CD 1:A:69:GLN:OE1 0.45 2.55 2 11:A:25:LYS:HD2 1:A:35:HIS:CE1 0.45 2.46 7 31:A:46:LYS:HA 1:A:49:GLU:OE2 0.45 2.12 7 11:A:75:HIS:O 1:A:75:HIS:CD2 0.45 2.69 9 11:A:30:ASP:CG 1:A:92:GLN:OE1 0.45 2.55 5 11:A:39:LYS:O 1:A:39:LYS:CG 0.45 2.65 3 21:A:23:LYS:CA 1:A:37:LYS:HD2 0.45 2.42 8 11:A:40:MET:CE 1:A:40:MET:HA 0.45 2.41 1 11:A:39:LYS:HE2 1:A:41:THR:OG1 0.45 2.12 4 11:A:36:PHE:CD1 1:A:36:PHE:C 0.45 2.89 8 11:A:50:SER:O 1:A:54:ARG:HD2 0.45 2.11 5 1
1:A:26:VAL:HG21 1:A:51:TYR:CZ 0.45 2.47 5 11:A:83:GLU:HG3 1:A:84:GLU:N 0.45 2.27 1 21:A:28:GLY:CA 1:A:90:VAL:O 0.45 2.65 2 21:A:66:PHE:CD2 1:A:71:ILE:CD1 0.44 2.99 1 11:A:52:CYS:HB3 1:A:57:VAL:HA 0.44 1.88 6 11:A:82:MET:HE2 1:A:85:GLU:O 0.44 2.12 1 11:A:78:LYS:HB3 1:A:79:GLU:OE1 0.44 2.12 2 11:A:45:LYS:HB3 1:A:73:ASP:CB 0.44 2.43 8 11:A:45:LYS:O 1:A:49:GLU:N 0.44 2.46 3 31:A:83:GLU:O 1:A:84:GLU:HG3 0.44 2.12 8 31:A:45:LYS:N 1:A:73:ASP:HB2 0.44 2.27 7 1
1:A:40:MET:CE 1:A:47:LEU:HB2 0.44 2.42 8 11:A:66:PHE:CD2 1:A:71:ILE:HD11 0.44 2.48 10 11:A:67:GLU:CD 1:A:79:GLU:OE2 0.44 2.56 4 11:A:63:ARG:HG3 1:A:70:ARG:HD3 0.44 1.88 7 11:A:52:CYS:CA 1:A:58:PRO:CD 0.44 2.95 5 11:A:52:CYS:CB 1:A:58:PRO:HD3 0.44 2.42 6 21:A:43:HIS:HB3 1:A:73:ASP:C 0.44 2.32 5 31:A:75:HIS:CE1 1:A:80:LEU:HD21 0.44 2.48 7 11:A:76:THR:OG1 1:A:77:PRO:HD3 0.44 2.13 5 11:A:34:ILE:HG21 1:A:51:TYR:HE1 0.44 1.72 8 11:A:75:HIS:ND1 1:A:78:LYS:HD3 0.44 2.28 10 11:A:23:LYS:HD2 1:A:37:LYS:CG 0.44 2.43 2 11:A:42:THR:HG21 1:A:46:LYS:HE3 0.44 1.89 3 1
1:A:22:ILE:O 1:A:22:ILE:HG12 0.44 2.13 7 11:A:22:ILE:HD11 1:A:40:MET:HG3 0.44 1.89 10 11:A:30:ASP:C 1:A:30:ASP:OD1 0.44 2.57 1 11:A:76:THR:HB 1:A:77:PRO:CD 0.44 2.41 1 1
Continued on next page...
Page 22 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:42:THR:C 1:A:43:HIS:CD2 0.44 2.92 3 11:A:50:SER:O 1:A:54:ARG:HG2 0.44 2.13 6 1
1:A:21:TYR:CE1 1:A:39:LYS:CG 0.44 3.01 9 11:A:52:CYS:SG 1:A:58:PRO:HG2 0.44 2.53 5 11:A:74:ASN:OD1 1:A:74:ASN:C 0.43 2.57 8 21:A:44:LEU:HD21 1:A:75:HIS:NE2 0.43 2.28 2 11:A:52:CYS:HA 1:A:58:PRO:CD 0.43 2.43 5 11:A:76:THR:N 1:A:80:LEU:HD12 0.43 2.28 7 11:A:64:PHE:O 1:A:70:ARG:HA 0.43 2.13 9 11:A:48:LYS:NZ 1:A:73:ASP:OD2 0.43 2.51 3 11:A:58:PRO:O 1:A:59:MET:C 0.43 2.57 7 1
1:A:63:ARG:HB3 1:A:91:TYR:HB2 0.43 1.91 4 11:A:73:ASP:OD1 1:A:73:ASP:C 0.43 2.55 5 11:A:78:LYS:HE3 1:A:79:GLU:CD 0.43 2.34 2 11:A:40:MET:SD 1:A:46:LYS:HB2 0.43 2.54 3 11:A:51:TYR:O 1:A:55:GLN:HB2 0.43 2.14 5 11:A:52:CYS:HB2 1:A:58:PRO:CD 0.43 2.43 3 11:A:34:ILE:HG22 1:A:36:PHE:HD1 0.43 1.73 10 11:A:58:PRO:HB3 1:A:62:LEU:HD22 0.43 1.91 5 11:A:74:ASN:O 1:A:74:ASN:OD1 0.42 2.36 2 11:A:75:HIS:CE1 1:A:79:GLU:HB2 0.42 2.48 2 11:A:22:ILE:O 1:A:37:LYS:CB 0.42 2.67 4 21:A:23:LYS:CB 1:A:37:LYS:HG2 0.42 2.45 5 2
1:A:24:LEU:HD22 1:A:47:LEU:HG 0.42 1.91 10 11:A:22:ILE:CD1 1:A:40:MET:HB3 0.42 2.44 5 11:A:26:VAL:O 1:A:26:VAL:HG23 0.42 2.14 1 11:A:22:ILE:O 1:A:37:LYS:HB3 0.42 2.14 9 4
1:A:24:LEU:CD2 1:A:88:ILE:CD1 0.42 2.91 2 11:A:65:LEU:HD21 1:A:69:GLN:CA 0.42 2.44 6 11:A:53:GLN:HA 1:A:57:VAL:CG1 0.42 2.45 7 11:A:45:LYS:HA 1:A:48:LYS:HG3 0.42 1.92 10 11:A:36:PHE:CZ 1:A:47:LEU:CD2 0.42 3.03 10 21:A:23:LYS:HD2 1:A:37:LYS:HD3 0.42 1.91 2 11:A:67:GLU:OE1 1:A:68:GLY:N 0.42 2.52 8 11:A:42:THR:O 1:A:43:HIS:O 0.42 2.38 1 11:A:47:LEU:CD1 1:A:47:LEU:C 0.42 2.85 6 11:A:63:ARG:CZ 1:A:70:ARG:HG2 0.42 2.45 6 11:A:44:LEU:O 1:A:48:LYS:HG2 0.42 2.13 7 1
1:A:83:GLU:HG2 1:A:84:GLU:N 0.42 2.30 7 11:A:65:LEU:CD1 1:A:65:LEU:C 0.42 2.88 8 11:A:33:GLU:CD 1:A:35:HIS:NE2 0.42 2.73 1 1
Continued on next page...
Page 23 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:66:PHE:CZ 1:A:88:ILE:HD11 0.42 2.49 7 11:A:44:LEU:HD23 1:A:75:HIS:NE2 0.42 2.30 7 11:A:24:LEU:CD2 1:A:88:ILE:HD12 0.41 2.40 2 11:A:63:ARG:HD3 1:A:70:ARG:CD 0.41 2.45 5 11:A:21:TYR:CD1 1:A:39:LYS:HB3 0.41 2.51 3 11:A:87:VAL:CG1 1:A:87:VAL:O 0.41 2.68 4 11:A:76:THR:CA 1:A:80:LEU:HB2 0.41 2.39 7 31:A:58:PRO:HA 1:A:62:LEU:HB2 0.41 1.92 3 11:A:58:PRO:CG 1:A:64:PHE:CE2 0.41 3.03 9 11:A:83:GLU:O 1:A:83:GLU:HG3 0.41 2.16 6 11:A:61:SER:OG 1:A:62:LEU:CD1 0.41 2.69 3 11:A:44:LEU:HD12 1:A:44:LEU:C 0.41 2.36 10 11:A:60:ASN:ND2 1:A:61:SER:N 0.41 2.69 10 11:A:23:LYS:CD 1:A:37:LYS:HD3 0.41 2.44 2 11:A:82:MET:HG3 1:A:85:GLU:O 0.41 2.16 2 11:A:65:LEU:C 1:A:65:LEU:CD1 0.41 2.89 7 11:A:44:LEU:C 1:A:44:LEU:HD12 0.41 2.36 9 11:A:23:LYS:O 1:A:85:GLU:HA 0.41 2.15 9 1
1:A:24:LEU:CD1 1:A:86:ASP:CG 0.41 2.87 10 11:A:52:CYS:CA 1:A:58:PRO:HD3 0.41 2.46 5 11:A:56:GLY:O 1:A:62:LEU:CD1 0.41 2.60 2 1
1:A:63:ARG:HD2 1:A:70:ARG:CD 0.41 2.46 8 11:A:44:LEU:HD21 1:A:72:ALA:O 0.41 2.15 10 11:A:58:PRO:HG2 1:A:64:PHE:CZ 0.41 2.51 5 11:A:26:VAL:CG2 1:A:34:ILE:HD11 0.41 2.36 2 11:A:65:LEU:HD11 1:A:69:GLN:CA 0.41 2.46 9 21:A:24:LEU:CD2 1:A:88:ILE:HD13 0.41 2.31 3 21:A:76:THR:H 1:A:77:PRO:HD2 0.41 1.76 6 11:A:63:ARG:NE 1:A:70:ARG:CG 0.41 2.84 6 11:A:63:ARG:HB3 1:A:91:TYR:O 0.41 2.16 4 11:A:24:LEU:HD22 1:A:86:ASP:OD2 0.40 2.16 1 11:A:40:MET:SD 1:A:44:LEU:HA 0.40 2.55 2 11:A:25:LYS:CB 1:A:34:ILE:O 0.40 2.69 4 11:A:65:LEU:O 1:A:89:GLU:N 0.40 2.52 7 1
1:A:64:PHE:CE2 1:A:90:VAL:CG1 0.40 3.04 10 11:A:75:HIS:H 1:A:75:HIS:CD2 0.40 2.34 10 11:A:48:LYS:O 1:A:52:CYS:CB 0.40 2.69 6 11:A:24:LEU:O 1:A:36:PHE:CD1 0.40 2.74 9 11:A:78:LYS:HG2 1:A:79:GLU:N 0.40 2.31 10 11:A:83:GLU:O 1:A:84:GLU:HG2 0.40 2.15 5 11:A:74:ASN:C 1:A:74:ASN:OD1 0.40 2.60 2 1
Continued on next page...
Page 24 Full wwPDB NMR Structure Validation Report 1A5R
Continued from previous page...
Atom-1 Atom-2 Clash(Å) Distance(Å)Models
Worst Total
1:A:62:LEU:HD21 1:A:90:VAL:CG1 0.40 2.46 7 11:A:22:ILE:CD1 1:A:40:MET:SD 0.40 3.09 10 11:A:64:PHE:CD2 1:A:90:VAL:HG13 0.40 2.51 10 11:A:50:SER:O 1:A:54:ARG:CG 0.40 2.69 1 11:A:36:PHE:CZ 1:A:47:LEU:HD11 0.40 2.51 2 11:A:40:MET:CE 1:A:46:LYS:CB 0.40 2.99 3 11:A:71:ILE:CD1 1:A:75:HIS:NE2 0.40 2.85 7 11:A:24:LEU:HD13 1:A:40:MET:HE3 0.40 1.93 8 1
6.3 Torsion angles iO
6.3.1 Protein backbone iO
In the following table, the Percentiles column shows the percent Ramachandran outliers of the chainas a percentile score with respect to all PDB entries followed by that with respect to all NMRentries. The Analysed column shows the number of residues for which the backbone conformationwas analysed and the total number of residues.
Mol Chain Analysed Favoured Allowed Outliers Percentiles
1 A 72/103 (70%) 59±2 (82±3%) 12±2 (16±3%) 2±1 (2±1%) 10 50
All All 720/1030 (70%) 590 (82%) 115 (16%) 15 (2%) 10 50
All 6 unique Ramachandran outliers are listed below. They are sorted by the frequency of occur-rence in the ensemble.
Mol Chain Res Type Models (Total)1 A 78 LYS 71 A 76 THR 31 A 57 VAL 21 A 68 GLY 11 A 60 ASN 11 A 43 HIS 1
6.3.2 Protein sidechains iO
In the following table, the Percentiles column shows the percent sidechain outliers of the chainas a percentile score with respect to all PDB entries followed by that with respect to all NMRentries. The Analysed column shows the number of residues for which the sidechain conformationwas analysed and the total number of residues.
Page 25 Full wwPDB NMR Structure Validation Report 1A5R
Mol Chain Analysed Rotameric Outliers Percentiles
1 A 67/92 (73%) 61±1 (91±1%) 6±1 (9±1%) 13 60
All All 670/920 (73%) 611 (91%) 59 (9%) 13 60
All 20 unique residues with a non-rotameric sidechain are listed below. They are sorted by thefrequency of occurrence in the ensemble.
Mol Chain Res Type Models (Total)1 A 90 VAL 101 A 22 ILE 101 A 48 LYS 91 A 60 ASN 51 A 36 PHE 41 A 52 CYS 31 A 42 THR 31 A 47 LEU 21 A 74 ASN 21 A 40 MET 11 A 39 LYS 11 A 63 ARG 11 A 65 LEU 11 A 83 GLU 11 A 70 ARG 11 A 76 THR 11 A 29 GLN 11 A 67 GLU 11 A 24 LEU 11 A 57 VAL 1
6.3.3 RNA iO
There are no RNA molecules in this entry.
6.4 Non-standard residues in protein, DNA, RNA chains iO
There are no non-standard protein/DNA/RNA residues in this entry.
6.5 Carbohydrates iO
There are no carbohydrates in this entry.
Page 26 Full wwPDB NMR Structure Validation Report 1A5R
6.6 Ligand geometry iO
There are no ligands in this entry.
6.7 Other polymers iO
There are no such molecules in this entry.
6.8 Polymer linkage issues iO
There are no chain breaks in this entry.
Page 27 Full wwPDB NMR Structure Validation Report 1A5R
7 Chemical shift validation iO
No chemical shift data were provided